ENDO Stock Overview
Develops and sells hemp based products. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Thermic Sciences International Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.000001 |
| 52 Week High | US$0.0001 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 11 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | 0% |
| 33 Year Change | -99.99% |
| 5 Year Change | -99.98% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| ENDO | US Personal Products | US Market | |
|---|---|---|---|
| 7D | 0% | 4.3% | 2.2% |
| 1Y | 0% | -12.0% | 31.6% |
Return vs Industry: ENDO exceeded the US Personal Products industry which returned -12% over the past year.
Return vs Market: ENDO underperformed the US Market which returned 31.6% over the past year.
Price Volatility
| ENDO volatility | |
|---|---|
| ENDO Average Weekly Movement | n/a |
| Personal Products Industry Average Movement | 8.6% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: ENDO's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine ENDO's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1969 | n/a | Raymond Dabney | www.omnicanna.com |
Thermic Sciences International develops and sells hemp based products. The company offers hemp formulation-based health and wellness solutions, as well as cosmeceuticals, nutraceuticals, and food brands. It also provides over the counter products for hair and skin include Hempery miracle oil, a skin care solution; Hemp milk body wash, a creamy soap; Hemp lotion bars for moisturizing hands and body; Hemp rose soap; and Hemtastique lip and body balms.
Thermic Sciences International Fundamentals Summary
| ENDO fundamental statistics | |
|---|---|
| Market cap | US$1.05k |
| Earnings (TTM) | -US$5.43m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio0.0x
P/E RatioIs ENDO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ENDO income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$5.43m |
| Earnings | -US$5.43m |
Last Reported Earnings
Mar 31, 2013
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did ENDO perform over the long term?
See historical performance and comparison